Overview

Kidney Damage in Patients With Moderate Fall in eGFR

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
To compare Iopamidol injection 370 and Iodixanol 320 in evaluating Neutrophil Gelatinase-Associated Lipocalin (NGAL) in patients with moderate fall in eGFR
Phase:
Phase 4
Details
Lead Sponsor:
Bracco Diagnostics, Inc